ANTHEM Ended Lower to ₹862.30: Inside the Block Deal Story Moving Anthem Biosciences Shares

Anthem Biosciences share price in Friday's session, and the reason behind it

Shares of Anthem Biosciences last changed hands at ₹862.30 on the NSE board at the close of the last trading session on Friday, 9 October 2026 — -10.25 or -1.17% from the previous close of ₹872.55. Behind the number, the move is inside the stock's usual daily range, so the tape is treating the story as information rather than as a reason to reprice.

Indian equity markets are shut on Saturday, so every level below is from the last trading session on Friday, 9 October 2026 and will not change until the next session opens.

The story in five lines

• Where it trades: Anthem Biosciences is at ₹862.30, -10.25 (-1.17%) versus the previous close of ₹872.55.
• Why it is moving: a block-deal story — one business desk filed on the company in the last few hours.
• Today's band: ₹842.20 to ₹880.20, against an open of ₹872.55 — the stock has given up its opening print.
• Twelve-month context: 11.79% below the ₹978 high and 48.89% above the ₹579 low, so the stock sits in the middle part of its own range.
• Participation: turnover is running at 0.2x the twenty-day average, which is ordinary flow — the move lacks a volume endorsement so far.
• What to watch: who the counterparties were and whether the buyer is a long-only fund or a trading desk, because a lock-in changes how much of the supply actually returns to the market.

The block deal angle

The reason Anthem Biosciences is on the desks in Friday's session is a block deal story — reported by one desk so far, with the headlines linked below. Large negotiated trades change the shareholder register in one print, and the discount or premium at which the block clears is the cleanest read on what institutions think the stock is worth today.

Live price snapshot

What a block deal tells you that the screen price does not

A block or bulk deal is a negotiated trade executed in one print, usually between an institution reducing a position and one or several buyers taking it on. Because both sides agree a price before the trade hits the tape, the discount or premium to the prevailing market price is the single cleanest read available on what large money thinks Anthem Biosciences is worth today.

The identity of the buyer matters more than the size. A long-only fund taking delivery implies the paper is off the market for quarters; an arbitrage or trading desk taking it implies the same stock returns as supply within weeks. Exchange bulk-deal disclosures name both sides after the close, which is why the day-after reaction is often more informative than the day-of one.

On the board, ANTHEM is at ₹862.30 against a session range of ₹842.20 to ₹880.20. If the block cleared inside that range, the market has already absorbed it; a block struck well below the range low usually caps the stock until the buyer stops adding.

Reading today's session

Anthem Biosciences has traded between ₹842.20 and ₹880.20 in this session against an open of ₹872.55 and a previous close of ₹872.55. That is a band of ₹38.00, or 4.41% of the current price — a wide day, which means intraday positions are being forced rather than chosen.

Trading below the open at ₹872.55 puts everyone who bought the first print underwater, and that cohort is the first source of supply on any bounce — which is why sessions that lose the open rarely close on the high.

In market-structure terms this is a continuation session, so the prior trend remains the base case until a level breaks.

The headlines behind this post

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.

• Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore — Economic Times

How the stock has performed

What the returns table is saying

Over the last week Anthem Biosciences has gained +0.43% and over the month -7.63%. The two horizons pointing in opposite directions is the signature of a counter-trend move — the shorter reading is either an early turn or a pullback inside the bigger trend, and volume is what separates the two.

The twelve-month return of +11.59% is the context long-term holders judge the stock on. A moderate one-year move means the stock has broadly tracked its earnings path rather than being re-rated in either direction.

Reading the price against its own ranges

Over the last twelve months the price has covered ₹579 to ₹978. The current level is 71% of the way through that band, 11.79% below the 52-week high and 48.89% above the 52-week low. A mid-range price means neither the bulls nor the bears own the trend yet; the twelve-month extremes are the levels that decide which way the range resolves.

Traded quantity of 1,87,250 shares is 0.24x the 20-day average of 7,88,902. Turnover this far below normal means the move is being made by very few hands, so the level is easier to reverse and worth treating as provisional.

What to watch next

For this block deal story specifically, watch who the counterparties were and whether the buyer is a long-only fund or a trading desk, because a lock-in changes how much of the supply actually returns to the market. On the chart, the ₹880.20 high and ₹842.20 low of the last session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of that low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 7,88,902 shares to be read as positioning rather than a squeeze.

So what should shareholders do with this?

For a trader, this is a low-information session: the move sits inside the stock's normal daily spread, so there is no edge in chasing it. Waiting for a close outside ₹842.20–₹880.20 is the cheaper way to be positioned.

For a long-term shareholder, supply-driven weakness is a different thing from deterioration. Nothing in this event changes what the company earns; it changes who owns it and at what price. The question worth asking is whether the post-event share count and the use of proceeds leave earnings per share better or worse than before.

On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.

Where that leaves the stock

Anthem Biosciences is being sold on a block-deal story, and at ₹862.30 the decline is happening on ordinary turnover, which is more often a shakeout than distribution. The day's ₹842.20–₹880.20 band is the frame for the next session, and who the counterparties were and whether the buyer is a long-only fund or a trading desk is what resolves the story either way.

Where to track ANTHEM next

Live price, charts and technicals stay on the Anthem Biosciences stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.

Frequently asked questions

What is the Anthem Biosciences share price in Friday's session?

Anthem Biosciences (ANTHEM) last traded at ₹862.30, -10.25 (-1.17%) against the previous close of ₹872.55, read from the NSE board at the close of the last trading session on Friday, 9 October 2026.

Why is Anthem Biosciences in the news in Friday's session?

1 business publisher ran headlines on the company in the last session — a block deal story. Their reports are linked above; the levels and tables here are read independently from exchange data.

What is the 52-week high and low of ANTHEM?

Over the last twelve months ANTHEM has traded between a low of ₹579 and a high of ₹978, computed from the adjusted daily series.

Is ANTHEM up or down in Friday's session?

ANTHEM slipped -1.17% in the last session, trading between ₹842.20 and ₹880.20 against an open of ₹872.55.

Is the market open right now?

No. Indian equity markets are shut on Saturday, so every level below is from the last trading session on Friday, 9 October 2026 and will not change until the next session opens.

Key takeaways

• Last price: ₹862.30 (-1.17%) — lower at the time of writing
• Day range: ₹842.20 – ₹880.20
• 52-week high: ₹978

About this report

Every figure on this page is read from a primary source at the timestamp shown — exchange boards for equities and indices, the exchange bid book for IPOs, published association rates for bullion, and consolidated exchange quotes for crypto — with no estimation or third-party commentary. Historical fields such as trailing returns and 52-week extremes are computed on the adjusted daily series so splits and bonuses do not create false gaps. A timestamp outside market hours reflects the last traded or last published value, not a live tick.

Related live pages

• Anthem Biosciences share price
• Anthem Biosciences quarterly results
• Stocks in news
• Top gainers
• Market dashboard

Sources

• NSE live board data via our exchange data feed
• Headline attribution links above point to the original publishers
• TrendRipperX Anthem Biosciences stock page

“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”